Previous findings from our group showed a positive correlation between the levels of interaction between CD27 and CD70 in the TME and sCD27 concentrations in plasma (Benhamouda et al, 2022), prompting us to measure these concentrations in patients with metastatic melanoma. The gene discussed is CD27; the disease is metastatic melanoma.